[Federal Register Volume 65, Number 51 (Wednesday, March 15, 2000)]
[Notices]
[Page 13981]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-6285]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Science Board to the Food and Drug Administration; Notice of 
Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Science Board to the Food and Drug 
Administration.
    General Function of the Committee: The board shall provide advice 
primarily to the agency's Senior Advisor for Science, and as needed, to 
the Commissioner of Food and Drugs and other appropriate officials on 
specific complex and technical issues as well as emerging issues within 
the scientific community in industry and academia. Additionally, the 
board will provide advice to the agency on keeping pace with technical 
and scientific evolutions in the fields of regulatory science, 
formulating an appropriate research agenda, and upgrading its 
scientific and research facilities to keep pace with these changes. It 
will also provide the means for critical review of agency-sponsored 
intramural and extramural scientific research programs.
    Date and Time: The meeting will be held on April 21, 2000, from 
8:30 a.m. to 5 p.m.
    Location: 5630 Fishers Lane, Rockville, MD 20852, Center for Drug 
Evaluation and Research Advisory Committee conference room 1066.
    Contact Person: Susan M. Bond, Office of the Senior Advisor for 
Science (HF-33), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-6687, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12603. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: Open committee discussion, 8:30 a.m. to 1:30 p.m.; open 
public hearing, 1:30 p.m. to 2 p.m., unless public participation does 
not last that long; open committee discussion, 2 p.m. to 5 p.m. The 
board will discuss their review of research at FDA's Center for Food 
Safety and Applied Nutrition (CFSAN). The board will also hear and 
discuss CFSAN's Dietary Supplement Strategic Plan, the Office of 
Women's Health research plan, joint FDA and industry training, and 
strategies for maintaining the quality of science at FDA.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the board. 
Written submissions may be made to the contact person by April 7, 2000. 
Oral presentations from the public will be scheduled between 
approximately 1:30 p.m. and 2 p.m. Time allotted for each presentation 
may be limited. Those desiring to make formal oral presentations should 
notify the contact person before April 7, 2000, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation. Each presenter will be limited in time and not all who 
request to speak may be accommodated.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: March 8, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-6285 Filed 3-14-00; 8:45 am]
BILLING CODE 4160-01-F